Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Each year, 40,000 cancer researchers, doctors, and industry executives gather here for the biggest meeting in ...

Good morning. Thirty-three days. That’s how long it took from the time AstraZeneca CEO Pascal Soriot greeted Virginia Governor Glenn Youngkin in his London office to announcing a $4 billion ...

AstraZeneca ( (GB:AZN)) just unveiled an announcement. AstraZeneca has disclosed that Chief Executive Officer Pascal Soriot received a vesting of 18,359 ordinary shares under the AstraZeneca ...

Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector ...

LONDON, Feb ⁠10 (Reuters) - ⁠AstraZeneca forecast steady profit growth in ⁠2026 on Tuesday, banking on strong demand for cancer drugs and new launches to offset patent losses and pricing pressure as ...

AstraZeneca is giving Pascal Soriot a pay raise as the longtime CEO weathered a year of “significant geopolitical uncertainty” to advance the British pharma toward an ambitious 2030 goal. For 2025, ...

The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...

AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more. Got a confidential news tip? We want to hear from you. Sign ...

Just days after President Donald Trump was elected in November, AstraZeneca unveiled a plan to invest an additional $2 billion, more than doubling its outlay to grow its manufacturing and R&D presence ...

AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.